LILRB1 and systemic lupus erythematosus: In SLE, this redistribution alters checkpoint engagement dynamics, potentially attenuating cytotoxicity via ILT2/KIR2DL4 signaling or impairing tolerogenic conditioning through ILT4 depletion (Tian et al., 2024; Wang et al., 2023).